STAT3 and neoplasm: KEVs encapsulating STAT3-targeting siRNA (siSTAT3) demonstrated enhanced structural integrity, targeted molecular recognition, and selective cytotoxicity in NSCLC cell lines, achieving substantial tumor growth inhibition in xenograft models [137].